Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2015 | 1 |
2016 | 3 |
2020 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Radiolabelled CCK2 R Antagonists Containing PEG Linkers: Design, Synthesis and Evaluation.
ChemMedChem. 2021 Jan 8;16(1):155-163. doi: 10.1002/cmdc.202000392. Epub 2020 Aug 3.
ChemMedChem. 2021.
PMID: 32643833
Development of the 99mTc-Labelled SST2 Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study.
Novak D, Janota B, Hörmann AA, Sawicka A, Kroselj M, Hubalewska-Dydejczyk A, Fani M, Mikolajczak R, Kolenc P, Decristoforo C, Garnuszek P.
Novak D, et al. Among authors: kroselj m.
Pharmaceutics. 2023 Mar 9;15(3):885. doi: 10.3390/pharmaceutics15030885.
Pharmaceutics. 2023.
PMID: 36986746
Free PMC article.
Item in Clipboard
Stereochemistry of amino acid spacers determines the pharmacokinetics of (111)In-DOTA-minigastrin analogues for targeting the CCK2/gastrin receptor.
Kolenc Peitl P, Tamma M, Kroselj M, Braun F, Waser B, Reubi JC, Sollner Dolenc M, Maecke HR, Mansi R.
Kolenc Peitl P, et al. Among authors: kroselj m.
Bioconjug Chem. 2015 Jun 17;26(6):1113-9. doi: 10.1021/acs.bioconjchem.5b00187. Epub 2015 May 20.
Bioconjug Chem. 2015.
PMID: 25971921
Item in Clipboard
A novel, self-shielded modular radiosynthesis system for fully automated preparation of PET and therapeutic radiopharmaceuticals.
Kroselj M, Socan A, Zaletel K, Dreger T, Knopp R, Gmeiner T, Kolenc Peitl P.
Kroselj M, et al.
Nucl Med Commun. 2016 Feb;37(2):207-14. doi: 10.1097/MNM.0000000000000411.
Nucl Med Commun. 2016.
PMID: 26443981
Item in Clipboard
From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial.
Pawlak D, Rangger C, Kolenc Peitl P, Garnuszek P, Maurin M, Ihli L, Kroselj M, Maina T, Maecke H, Erba P, Kremser L, Hubalewska-Dydejczyk A, Mikołajczak R, Decristoforo C.
Pawlak D, et al. Among authors: kroselj m.
Eur J Pharm Sci. 2016 Mar 31;85:1-9. doi: 10.1016/j.ejps.2016.01.023. Epub 2016 Jan 27.
Eur J Pharm Sci. 2016.
PMID: 26826279
Free PMC article.
Item in Clipboard
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with (111)In-CP04 in medullary thyroid carcinoma patients.
Maina T, Konijnenberg MW, KolencPeitl P, Garnuszek P, Nock BA, Kaloudi A, Kroselj M, Zaletel K, Maecke H, Mansi R, Erba P, von Guggenberg E, Hubalewska-Dydejczyk A, Mikolajczak R, Decristoforo C.
Maina T, et al. Among authors: kroselj m.
Eur J Pharm Sci. 2016 Aug 25;91:236-42. doi: 10.1016/j.ejps.2016.05.011. Epub 2016 May 14.
Eur J Pharm Sci. 2016.
PMID: 27185299
Free PMC article.
Item in Clipboard
Influence of radiation source geometry on determination of (111)In and (90)Y activity of radiopharmaceuticals.
Peitl PK, Tomse P, Kroselj M, Socan A, Hojker S, Pecar S, Stopar TG.
Peitl PK, et al. Among authors: kroselj m.
Nucl Med Commun. 2009 Oct;30(10):807-14. doi: 10.1097/MNM.0b013e32832fd0ea.
Nucl Med Commun. 2009.
PMID: 19623093
Item in Clipboard
Cite
Cite